# Optimizing IFN Beta - 1B Dose

> **NCT00473213** · PHASE3 · COMPLETED · sponsor: **University of Turin, Italy** · enrollment: 217 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon Beta 1

## Key facts

- **NCT ID:** NCT00473213
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2007-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00473213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00473213, "Optimizing IFN Beta - 1B Dose". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00473213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*